Home › Funds › BRISTOL JOHN W & CO INC /NY/ › NVS
BRISTOL JOHN W & CO INC /NY/ position in NVS
NOVARTIS AG · Health Care
BRISTOL JOHN W & CO INC /NY/ reported holding 545,446 shares of NVS (NOVARTIS AG) in its Q3 2026 13F filing — a position valued at US$77.8M, representing 1.18% of its reported portfolio and ranking #37 among its reported holdings. BRISTOL JOHN W & CO INC /NY/ has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How BRISTOL JOHN W & CO INC /NY/'s NVS position evolved
BRISTOL JOHN W & CO INC /NY/ first disclosed a stake in NVS in Q3 2023 at 675,409 shares (US$68.8M). The position peaked in Q2 2026 at 557,777 shares, worth US$87.4M. Across 13 filings, BRISTOL JOHN W & CO INC /NY/ increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 545,446 shares valued at US$77.8M — a reduction of -12,331 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 675.41K | $68.80M | New |
| Q4 2023 | 642.75K | $64.90M | Reduce |
| Q1 2024 | 638.56K | $61.77M | Reduce |
| Q2 2024 | 624.92K | $66.53M | Reduce |
| Q3 2024 | 623.71K | $71.74M | Hold |
| Q4 2024 | 609.68K | $59.33M | Reduce |
| Q1 2025 | 593.73K | $66.19M | Reduce |
| Q2 2025 | 592.28K | $71.67M | Hold |
| Q3 2025 | 581.72K | $74.60M | Reduce |
| Q4 2025 | 569.72K | $78.55M | Reduce |
| Q1 2026 | 561.84K | $85.82M | Reduce |
| Q2 2026 | 557.78K | $87.41M | Reduce |
| Q3 2026 | 545.45K | $77.76M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (NOVARTIS AG) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 16.76M sh · $2.39B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $938.89M · Q3 2026
- LOOMIS SAYLES & CO L P 4.83M sh · $689.20M · Q3 2026
- Cullen Capital Management, LLC 1.95M sh · $278.55M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.72M sh · $250.18M · Q3 2026
More on BRISTOL JOHN W & CO INC /NY/
FAQ
How long has BRISTOL JOHN W & CO INC /NY/ held NVS?
BRISTOL JOHN W & CO INC /NY/ has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BRISTOL JOHN W & CO INC /NY/'s current position in NVS?
As of Q3 2026, BRISTOL JOHN W & CO INC /NY/ holds 545.45K shares of NVS (NOVARTIS AG), valued at $77.76M, representing 1.18% of its reported portfolio and ranking #37.
Has BRISTOL JOHN W & CO INC /NY/ been buying or selling NVS?
In the latest 13F filing (Q3 2026), BRISTOL JOHN W & CO INC /NY/ reduced its position in NVS. The position peaked in Q2 2026 at 557.78K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.